![](https://ml.globenewswire.com/media/0c144980-c514-47b2-ad03-4f286ded7ae9/small/evelo-logo-png.png)
Evelo Biosciences Announces Pricing of Public Offering of Common Stock
CAMBRIDGE, Mass., June 24, 2020 (GLOBE NEWSWIRE) -- Evelo Biosciences, Inc. (Nasdaq: EVLO) (“Evelo”), a clinical stage biotechnology company developing a new modality of orally delivered, systemically acting biologic therapies, today announced the pricing …